Philipp Knechtle

998 total citations
20 papers, 661 citations indexed

About

Philipp Knechtle is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Philipp Knechtle has authored 20 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 10 papers in Epidemiology and 10 papers in Molecular Medicine. Recurrent topics in Philipp Knechtle's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Fungal and yeast genetics research (8 papers). Philipp Knechtle is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Fungal and yeast genetics research (8 papers). Philipp Knechtle collaborates with scholars based in Switzerland, United States and United Kingdom. Philipp Knechtle's co-authors include Peter Philippsen, Jürgen Wendland, Fred S. Dietrich, Corinne Rebischung, Adam Belley, Ian Morrissey, Stephen Hawser, Stuart Shapiro, Sophie Magnet and Stephen A. Goff and has published in prestigious journals such as JAMA, Journal of Cell Science and Journal of Clinical Microbiology.

In The Last Decade

Philipp Knechtle

20 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Knechtle Switzerland 13 377 252 199 130 125 20 661
Joanne Livermore United Kingdom 15 88 0.2× 184 0.7× 63 0.3× 510 3.9× 58 0.5× 16 768
Sagar Lahiri India 8 123 0.3× 120 0.5× 179 0.9× 55 0.4× 36 0.3× 17 327
Mohsen Chitsaz Iran 9 110 0.3× 44 0.2× 169 0.8× 50 0.4× 92 0.7× 18 418
Jaspal Kaur India 13 81 0.2× 16 0.1× 156 0.8× 45 0.3× 205 1.6× 51 496
Malin Kvist Sweden 4 203 0.5× 45 0.2× 153 0.8× 36 0.3× 21 0.2× 5 337
A J Godfrey Canada 14 186 0.5× 126 0.5× 232 1.2× 91 0.7× 20 0.2× 17 443
Laura Dabos France 12 187 0.5× 217 0.9× 656 3.3× 99 0.8× 33 0.3× 24 748
Mariana Pagano Argentina 11 172 0.5× 40 0.2× 211 1.1× 16 0.1× 85 0.7× 18 391
Hayley Wilson United Kingdom 7 96 0.3× 22 0.1× 74 0.4× 28 0.2× 111 0.9× 10 314
Domenico Setacci Italy 13 124 0.3× 96 0.4× 229 1.2× 39 0.3× 48 0.4× 18 443

Countries citing papers authored by Philipp Knechtle

Since Specialization
Citations

This map shows the geographic impact of Philipp Knechtle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Knechtle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Knechtle more than expected).

Fields of papers citing papers by Philipp Knechtle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Knechtle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Knechtle. The network helps show where Philipp Knechtle may publish in the future.

Co-authorship network of co-authors of Philipp Knechtle

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Knechtle. A scholar is included among the top collaborators of Philipp Knechtle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Knechtle. Philipp Knechtle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Das, Shampa, Richard J. Fitzgerald, Asad Ullah, et al.. (2020). Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia. Antimicrobial Agents and Chemotherapy. 65(1). 25 indexed citations
5.
Johnson, Adam, Laura McEntee, Nicola Farrington, et al.. (2020). Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 64(6). 27 indexed citations
7.
Odedra, Rajesh, Sylvie Sordello, Cédric Charrier, et al.. (2020). Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. 64(6). 25 indexed citations
8.
Carmeli, Yehuda, Philipp Knechtle, J. Hardenberg, & Mathias Knecht. (2019). 1477. A Randomized Phase 2 Study of Cefepime Combined with the Novel Extended Spectrum β-Lactamase Inhibitor Enmetazobactam in Hospitalized Adults with Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP). Open Forum Infectious Diseases. 6(Supplement_2). S539–S539. 3 indexed citations
9.
10.
Morrissey, Ian, Sophie Magnet, Stephen Hawser, Stuart Shapiro, & Philipp Knechtle. (2019). In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014–2015. Antimicrobial Agents and Chemotherapy. 63(7). 65 indexed citations
11.
Knechtle, Philipp, Harald Heider, Museer A. Lone, et al.. (2013). The Natural Diyne-Furan Fatty Acid EV-086 Is an Inhibitor of Fungal Delta-9 Fatty Acid Desaturation with Efficacy in a Model of Skin Dermatophytosis. Antimicrobial Agents and Chemotherapy. 58(1). 455–466. 12 indexed citations
12.
Knechtle, Philipp, Andreas M. Kaufmann, Daniele Cavicchioli, & Peter Philippsen. (2008). The Paxillin-like protein AgPxl1 is required for apical branching and maximal hyphal growth in A. gossypii. Fungal Genetics and Biology. 45(6). 829–838. 9 indexed citations
13.
Goyard, Sophie, Philipp Knechtle, Murielle Chauvel, et al.. (2008). The Yak1 Kinase Is Involved in the Initiation and Maintenance of Hyphal Growth inCandida albicans. Molecular Biology of the Cell. 19(5). 2251–2266. 47 indexed citations
14.
Knechtle, Philipp, Jürgen Wendland, & Peter Philippsen. (2006). The SH3/PH Domain Protein AgBoi1/2 Collaborates with the Rho-Type GTPaseAgRho3 To Prevent Nonpolar Growth at Hyphal Tips of Ashbyagossypii. Eukaryotic Cell. 5(10). 1635–1647. 20 indexed citations
15.
Knechtle, Philipp, Sophie Goyard, Sophie Brachat, Oumaïma Ibrahim-Granet, & Christophe d’Enfert. (2005). Phosphatidylinositol-dependent phospholipases C Plc2 and Plc3 of Candida albicans are dispensable for morphogenesis and host–pathogen interaction. Research in Microbiology. 156(7). 822–829. 7 indexed citations
16.
Bauer, Yasmina, et al.. (2004). A Ras-like GTPase Is Involved in Hyphal Growth Guidance in the Filamentous FungusAshbya gossypii. Molecular Biology of the Cell. 15(10). 4622–4632. 60 indexed citations
17.
Knechtle, Beat, et al.. (2004). Energieumsatz bei Langstreckenschwimmen - eine Fallbeschreibung. 4 indexed citations
18.
Knechtle, Philipp, Fred S. Dietrich, & Peter Philippsen. (2003). Maximal Polar Growth Potential Depends on the Polarisome Component AgSpa2 in the Filamentous FungusAshbya gossypii. Molecular Biology of the Cell. 14(10). 4140–4154. 78 indexed citations
19.
Wendland, Jürgen, et al.. (2000). PCR-based gene targeting in the filamentous fungus Ashbya gossypii. Gene. 242(1-2). 381–391. 111 indexed citations
20.
Knechtle, Philipp, et al.. (2000). A PAK-like protein kinase is required for maturation of young hyphae and septation in the filamentous ascomycete Ashbya gossypii. Journal of Cell Science. 113(24). 4563–4575. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026